Company registration number 14791823 (England and Wales)
MEDGATE PRIME LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2026
PAGES FOR FILING WITH REGISTRAR
MEDGATE PRIME LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MEDGATE PRIME LTD
BALANCE SHEET
AS AT
30 APRIL 2026
30 April 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Intangible assets
3
262,529
Tangible assets
4
36,128
298,657
Current assets
Stocks
18,391
-
Debtors
5
73,911
Cash at bank and in hand
114,350
206,652
Creditors: amounts falling due within one year
6
(253,388)
(14,772)
Net current liabilities
(46,736)
(14,772)
Total assets less current liabilities
251,921
(14,772)
Creditors: amounts falling due after more than one year
7
(221,241)
Provisions for liabilities
(9,032)
-
Net assets/(liabilities)
21,648
(14,772)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
21,548
(14,872)
Total equity
21,648
(14,772)
MEDGATE PRIME LTD
BALANCE SHEET (CONTINUED)
AS AT
30 APRIL 2026
30 April 2026
- 2 -
For the financial year ended 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved and signed by the director and authorised for issue on 16 September 2026
Mr KD Oduro
Director
Company registration number 14791823 (England and Wales)
MEDGATE PRIME LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2026
- 3 -
1
Accounting policies
Company information
Medgate Prime Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Elthorne Gate, 64 High Street, Pinner, England, HA5 5QA.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The Company did not trade during the previous financial year and commenced trading during the current financial year. The comparative figures therefore reflect the Company’s pre-trading position and are not directly comparable with the current year results.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.
When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.
1.4
Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.
For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
MEDGATE PRIME LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
1
Accounting policies
(Continued)
- 4 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
25% reducing balance
Computers
25% reducing balance
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.7
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.8
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.9
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
MEDGATE PRIME LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 5 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2026
2025
Number
Number
Total
4
1
3
Intangible fixed assets
Goodwill
£
Cost
At 1 May 2025
Additions
276,346
At 30 April 2026
276,346
Amortisation and impairment
At 1 May 2025
Amortisation charged for the year
13,817
At 30 April 2026
13,817
Carrying amount
At 30 April 2026
262,529
At 30 April 2025
4
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 May 2025
Additions
45,290
2,347
47,637
At 30 April 2026
45,290
2,347
47,637
Depreciation and impairment
At 1 May 2025
Depreciation charged in the year
11,323
186
11,509
At 30 April 2026
11,323
186
11,509
MEDGATE PRIME LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
4
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
(Continued)
- 6 -
Carrying amount
At 30 April 2026
33,967
2,161
36,128
At 30 April 2025
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
57,859
Other debtors
11,670
Prepayments and accrued income
4,382
73,911
-
6
Creditors: amounts falling due within one year
2026
2025
£
£
Bank loans
14,820
Trade creditors
51,117
Taxation and social security
14,249
Other creditors
173,202
14,772
253,388
14,772
7
Creditors: amounts falling due after more than one year
2026
2025
Notes
£
£
Bank loans and overdrafts
221,241
Creditors which fall due after five years are payable as follows:
Payable by instalments
161,961
-
MEDGATE PRIME LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
7
Creditors: amounts falling due after more than one year
(Continued)
- 7 -
The bank loans and overdrafts falling due within one year and after more than one year are secured by fixed and floating charges over the assets of the Company.
The following assets held as security are charged to Barclays:
1) A guarantee of £60,000 provided by Mr KD Oduro;
2) A legal charge over 14 Main Street, Sprotbrough, Doncaster held by Barclays Security Trustee Limited for the benefit of Barclays Bank UK plc and Barclays Bank plc;
3) A debenture granted by Medgate Prime Ltd held by Barclays Security Trustee Limited for the benefit of Barclays Bank UK plc and Barclays Bank plc.
8
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2026
2025
£
£
Total commitments
179,000